Prostate Cancer - Results from #23140

A reference set of health utilities for long-term survivors of prostate cancer: Population-based data from Ontario, Canada - Abstract May 21, 2013

Comparison of biochemical recurrence free survival between periprostatic and pelvic lymph node metastases of prostate cancer - Abstract May 21, 2013

Multiparametric MR imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard - Abstract May 21, 2013

Delayed radiotherapy for patients with localized prostate cancer: Validation by propensity score matching - Abstract May 21, 2013

Improved therapeutic targeting of the androgen receptor: Rational drug design improves survival in castration-resistant prostate cancer - Abstract May 21, 2013

Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinoma - Abstract May 21, 2013

Dietary supplements and prostate cancer: A systematic review of double-blind, placebo-controlled randomised clinical trials - Abstract May 21, 2013

Statin use and risk of prostate cancer and high-grade prostate cancer: Results from the REDUCE study - Abstract May 21, 2013

Optimal therapy sequencing in metastatic castration-resistant prostate cancer - Abstract May 21, 2013

Comparison of three versions of Partin tables to predict final pathologic stage in a Chinese cohort: A decision curve analysis - Abstract May 21, 2013

Diffusion pattern of low dose rate brachytherapy for prostate cancer in Japan - Abstract May 21, 2013

The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer - Abstract May 21, 2013

Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: The PROSTQA experience - Abstract May 21, 2013

The fat side of prostate cancer - Abstract May 21, 2013

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D - Abstract May 21, 2013

Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer - Abstract May 21, 2013

Prostate volume as an independent predictor of prostate cancer in men with PSA of 10-50 ng ml(-1) - Abstract May 21, 2013

Prostate cancer risk-associated genetic markers and their potential clinical utility - Abstract May 21, 2013

Sleep disruption among older men and risk of prostate cancer - Abstract May 20, 2013

Monitor unit optimization in RapidArc plans for prostate cancer - Abstract May 20, 2013

Page 1158 of 1435